Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance
Israel Biotech Fund identified the opportunity, led the due diligence and syndicated with aMoon and Harel Insurance in 2017 to form Ayala. Read the full Article
News
Gamida Cell $40MM Financing to support its Phase 3 Trial
Israel Biotech Fund participated in Gamida Cell’s $40MM financing round which shall support the ongoing Phase 3 trial of the its FDA Breakthrough Designated clinical-stage product, NiCord, to facilitate bone marrow transplantation. Read the full Article
Israel Biotech Fund Co-Founder and General Partner Recognized for Contribution to Liquid Biopsy Innovation
American Association for Cancer Research (AACR) Bestows 2017 Team Science Award to a Renowned Team of Investigators who Pioneered the Science of Liquid Biopsy: Luis A. Diaz, Nishant Agrawazl, Chetan Bettegowda, Frank Diehl, Peter Gibbs, Stanley R. Hamilton, Ralph H. Hruban, Hartmut Juhl, Isaac Kinde, Kenneth Kinzler, Martin Nowak, Nickolas Papadopoulos, David Sidransky, Jeanne Tie, Victor E. Velculescu, Bert Vogelstein Israel Biotech … …
Israel Biotech Fund invests in Pharma Two B
A $30MM funding round in Pharma Two B was led by Israel Biotech Fund, which syndicated the investment with leading US and Israeli investors. Read the full Article
Israel Biotech Fund begins investing
Israel Biotech Fund, founded to make investments in the Israeli biotech industry, today selected cancer drug developer Vidac for its first investment.Read the full Article
Biogen invests in a newly formed Israeli fund
Biogen invests in a newly formed fund dedicated to investment in Israeli and Israeli related biotech companies.Read the full Article